Hepatic stellate cells and liver retinoid content in alcoholic liver disease in humans

被引:12
|
作者
Hautekeete, ML
Dodeman, I
Azais-Braesco, V
Van den Berg, K
Seynaeve, C
Geerts, A
机构
[1] Free Univ Brussels, Cell Biol & Histol Lab, B-1090 Brussels, Belgium
[2] INRA, Lab Malad Metab & Micronutriments, Equipe Vitamines, Clermont Ferrand, France
关键词
hepatic stellate cell; Ito cell; retinoids; alcoholic liver disease; lipids;
D O I
10.1111/j.1530-0277.1998.tb03678.x
中图分类号
R194 [卫生标准、卫生检查、医药管理];
学科分类号
摘要
Body retinoids are stored in the lipid droplets of hepatic stellate (Ito) cells. In chronic liver disease, the stellate cells differentiate into myofibroblast-like cells, a process whereby they lose their retinoid-containing lipid droplets. We studied the relation between liver retinoid content, the number of lipid droplets per stellate cell, and the number of stellate cells per mm(2) in human alcoholic liver disease, Semithin sections of liver biopsies from normal subjects and patients with early (steatosis, inflammation, and mild fibrosis) and late (cirrhosis and cirrhosis with acute alcoholic hepatitis) alcoholic liver disease were morphometrically evaluated. Liver retinoid content was determined by HPLC. In normal patients, liver retinoid content was 901 +/- 213 IU/g of liver (mean +/- SEM), There was a decrease in liver retinoid content in early alcoholic liver disease (409 +/- 50 IU/g) and a further reduction in cirrhosis (153 +/- 50 IU/g). In patients with acute alcoholic hepatitis, retinoid content was strikingly low (5.2 +/- 1.8 IU/g), There was a progressive decrease in the number of stellate cells per mm(2) associated with progressive liver damage. We found a fair correlation between the number of stellate cells per mm(2) and liver retinoid content in all patient groups (overall correlation: 0.71). In normal subjects, the mean number of lipid droplets per stellate cell was 7.4 +/- 0.7. In patients with early alcoholic liver disease and in patients with alcoholic cirrhosis, this value was increased to 13.6 +/- 0.8 and 10.4 +/- 2.0, respectively. In patients with acute alcoholic hepatitis, only a few lipid droplets were present (4.2 +/- 0.5). There was a good correlation between liver retinoid content and mean number of lipid droplets in normal patients (r = 0.58). In alcoholic cirrhosis, however, correlation was poor (r = 0.34). In early alcoholic liver disease, the correlation was absent (r = 0.004). In conclusion, the major finding of our study is that the correlation between the mean number of lipid droplets per stellate cell and liver retinoid content varies according to the hepatic pathology considered. Marked lipid droplet accumulation occurs in stellate cells in early alcoholic liver disease and, to a lesser extent, in alcoholic cirrhosis, but there is no correlation between the mean number of lipid droplets per stellate cell and liver retinoid content. Therefore, not retinoids but probably lipids are responsible for the accumulation of lipid droplets. We also find that there is a fair correlation between the number of stellate cells per mm(2) and liver retinoid content in all patient groups. Finally, we confirm the decrease in hepatic retinoid content that occurs in alcoholic liver disease in humans, even af:the early stages of the disease.
引用
收藏
页码:494 / 500
页数:7
相关论文
共 50 条
  • [41] Hepatic stellate cells: a target for the treatment of liver fibrosis
    Jian Wu
    Mark A. Zern
    Journal of Gastroenterology, 2000, 35 : 665 - 672
  • [42] Succinate as a Regulator of Hepatic Stellate Cells in Liver Fibrosis
    Cho, Eun-Hee
    FRONTIERS IN ENDOCRINOLOGY, 2018, 9
  • [43] Hematopoietic origin of hepatic stellate cells in the adult liver
    Miyata, Eri
    Masuya, Masahiro
    Yoshida, Shuro
    Nakamura, Shiho
    Kato, Keizo
    Sugimoto, Yuka
    Shibasaki, Tetsunori
    Yamamura, Kentaro
    Ohishi, Kohshi
    Nishii, Kazuhiro
    Ishikawa, Fumihiko
    Shiku, Hiroshi
    Katayama, Naoyuki
    BLOOD, 2008, 111 (04) : 2427 - 2435
  • [44] Hepatic stellate cells as key target in liver fibrosis
    Higashi, Takaaki
    Friedman, Scott L.
    Hoshida, Yujin
    ADVANCED DRUG DELIVERY REVIEWS, 2017, 121 : 27 - 42
  • [45] Hepatic Stellate Cells: Partners in Crime for Liver Metastases?
    Kang, Ningling
    Gores, Gregory J.
    Shah, Vijay H.
    HEPATOLOGY, 2011, 54 (02) : 707 - 713
  • [46] Metabolic Hallmarks of Hepatic Stellate Cells in Liver Fibrosis
    Khomich, Olga
    Ivanov, Alexander V.
    Bartosch, Birke
    CELLS, 2020, 9 (01)
  • [47] Hepatic stellate cells in liver development, regeneration, and cancer
    Yin, Chunyue
    Evason, Kimberley J.
    Asahina, Kinji
    Stainier, Didier Y. R.
    JOURNAL OF CLINICAL INVESTIGATION, 2013, 123 (05): : 1902 - 1910
  • [48] Hepatic stellate cells as a target for the treatment of liver fibrosis
    Bataller, R
    Brenner, DA
    SEMINARS IN LIVER DISEASE, 2001, 21 (03) : 437 - 451
  • [49] Relaxin receptors in hepatic stellate cells and cirrhotic liver
    Bennett, Robert G.
    Dalton, Shana R.
    Mahan, Katrina J.
    Gentry-Nielsen, Martha J.
    Hamel, Frederick G.
    Tuma, Dean J.
    BIOCHEMICAL PHARMACOLOGY, 2007, 73 (07) : 1033 - 1040
  • [50] Hepatic Stellate Cells Functional Heterogeneity in Liver Cancer
    Sererols-Vinas, Laura
    Garcia-Vicien, Gemma
    Ruiz-Blazquez, Paloma
    Lee, Ting-Fang
    Lee, Youngmin A.
    Gonzalez-Sanchez, Ester
    Vaquero, Javier
    Moles, Anna
    Filliol, Aveline
    Affo, Silvia
    SEMINARS IN LIVER DISEASE, 2025,